Search Results - "Shaji Sebastian"

Refine Results
  1. 1

    Letter: should we intensify infliximab in acute severe ulcerative colitis? Author's reply by Sebastian, Shaji

    Published in Alimentary pharmacology & therapeutics (01-01-2020)
    “…LINKED CONTENTThis article is linked to Sebastian et al and Laharie and Rivière papers. To view these articles, visit https://doi.org/10.1111/apt.15456 and…”
    Get full text
    Journal Article
  2. 2

    Letter: infliximab induction regimens in steroid‐refractory acute severe colitis—a propensity score analysis. Authors' reply by Sebastian, Shaji, Myers, Sally

    Published in Alimentary pharmacology & therapeutics (01-03-2020)
    “…LINKED CONTENTThis article is linked to Sebastian et al and Li Wai Suen et al papers. To view these articles, visit https://doi.org/10.1111/apt.15456 and…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Practical guidance for the management of inflammatory bowel disease in patients with cancer. Which treatment? by Sebastian, Shaji, Neilaj, Steven

    Published in Therapeutic Advances in Gastroenterology (01-01-2019)
    “…Clinicians involved in the treatment of inflammatory bowel disease (IBD) increasingly come across patients with current or previous history of malignancies…”
    Get full text
    Book Review Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease by Marsal, Jan, Barreiro-de Acosta, Manuel, Blumenstein, Irina, Cappello, Maria, Bazin, Thomas, Sebastian, Shaji

    Published in Frontiers in medicine (15-06-2022)
    “…Anti-tumor necrosis factor (anti-TNF) therapy has been successfully used as first-line biologic treatment for moderate-to-severe inflammatory bowel disease…”
    Get full text
    Journal Article
  16. 16

    Editorial: the impact of COVID on the management of IBD flares: different care but similar outcomes—authors' reply by Saifuddin, Aamir, Kent, Alexandra J., Mehta, Shameer J., Sebastian, Shaji

    Published in Alimentary pharmacology & therapeutics (01-01-2023)
    “…LINKED CONTENT This article is linked to Saifuddin et al papers. To view these articles, visit https://doi.org/10.1111/apt.17223 and…”
    Get full text
    Journal Article
  17. 17

    Artificial intelligence for discrimination of Crohn's disease and gastrointestinal tuberculosis: A systematic review by Sachan, Anurag, Kakadiya, Rinkalben, Mishra, Shubhra, Kumar‐M, Praveen, Jena, Anuraag, Gupta, Pankaj, Sebastian, Shaji, Deepak, Parakkal, Sharma, Vishal

    Published in Journal of gastroenterology and hepatology (01-03-2024)
    “…Background and Aim Discrimination of gastrointestinal tuberculosis (GITB) and Crohn's disease (CD) is difficult. Use of artificial intelligence (AI)‐based…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Editorial: accelerated infliximab induction—it's time to settle the debate! Authors' reply by Sebastian, Shaji, Kennedy, Nicholas A., Subramanian, Sreedhar, Raine, Tim

    Published in Alimentary pharmacology & therapeutics (01-11-2019)
    “…LINKED CONTENTThis article is linked to Sebastian et al and Chedid and Kane papers. To view these articles, visit https://doi.org/10.1111/apt.15456 and…”
    Get full text
    Journal Article